| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
|
N Engl J Med
|
2014
|
5.37
|
|
2
|
Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.
|
J Clin Oncol
|
2012
|
5.08
|
|
3
|
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.
|
Nat Genet
|
2011
|
4.93
|
|
4
|
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
|
Blood
|
2006
|
3.91
|
|
5
|
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.
|
Blood
|
2012
|
2.09
|
|
6
|
Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides.
|
Pediatr Blood Cancer
|
2013
|
1.97
|
|
7
|
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.
|
Blood
|
2012
|
1.90
|
|
8
|
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
|
J Clin Oncol
|
2008
|
1.83
|
|
9
|
Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
|
J Natl Cancer Inst
|
2013
|
1.81
|
|
10
|
Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group.
|
Blood
|
2010
|
1.67
|
|
11
|
Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse.
|
Nat Genet
|
2013
|
1.45
|
|
12
|
ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.
|
J Clin Oncol
|
2012
|
1.39
|
|
13
|
Risk factors for readmission after initial diagnosis in children with acute lymphoblastic leukemia.
|
Pediatr Blood Cancer
|
2008
|
1.39
|
|
14
|
Methotrexate polyglutamation may lack prognostic significance in children with B-cell precursor acute lymphoblastic leukemia treated with intensive oral methotrexate.
|
J Pediatr Hematol Oncol
|
2002
|
1.38
|
|
15
|
Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.
|
Pediatr Blood Cancer
|
2012
|
1.29
|
|
16
|
Genome-wide study of methotrexate clearance replicates SLCO1B1.
|
Blood
|
2012
|
1.17
|
|
17
|
Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.
|
J Clin Oncol
|
2013
|
1.07
|
|
18
|
Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies.
|
Pharmacogenetics
|
2002
|
1.03
|
|
19
|
Childhood leukemia--new advances and challenges.
|
N Engl J Med
|
2004
|
0.96
|
|
20
|
Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
|
J Clin Oncol
|
2003
|
0.96
|
|
21
|
Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.
|
Blood
|
2013
|
0.95
|
|
22
|
A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
|
Cancer
|
2014
|
0.92
|
|
23
|
Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.90
|
|
24
|
Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
|
J Neurosurg
|
2007
|
0.84
|
|
25
|
Effects of intraventricular methotrexate on folate, adenosine, and homocysteine metabolism in cerebrospinal fluid.
|
J Pediatr Hematol Oncol
|
2004
|
0.83
|
|
26
|
Candidate gene association analysis of acute lymphoblastic leukemia identifies new susceptibility locus at 11p15 (LMO1).
|
Carcinogenesis
|
2011
|
0.82
|
|
27
|
Multilocus association of genetic variants in MLL, CREBBP, EP300, and TOP2A with childhood acute lymphoblastic leukemia in Hispanics from Texas.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.82
|
|
28
|
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference.
|
Pediatr Blood Cancer
|
2010
|
0.82
|
|
29
|
Therapy of low-risk subsets of childhood acute lymphoblastic leukemia: when do we say enough?
|
Pediatr Blood Cancer
|
2005
|
0.81
|
|
30
|
Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).
|
Pediatr Blood Cancer
|
2014
|
0.80
|
|
31
|
Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumors.
|
Pediatr Blood Cancer
|
2004
|
0.80
|
|
32
|
Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group.
|
J Pediatr Hematol Oncol
|
2012
|
0.79
|
|
33
|
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group.
|
Pediatr Blood Cancer
|
2014
|
0.78
|
|
34
|
Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph+ ALL: a Children's Oncology Group (COG) study.
|
Br J Haematol
|
2012
|
0.77
|
|
35
|
A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1.
|
J Pediatr Hematol Oncol
|
2016
|
0.75
|
|
36
|
Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study.
|
J Clin Oncol
|
2004
|
0.75
|
|
37
|
Rapidly fatal acute bacterial myocarditis in a nonneutropenic child with acute lymphoblastic leukemia in remission.
|
J Pediatr Hematol Oncol
|
2002
|
0.75
|